ISV – I saw this post on the PFE board on InvestorVillage:
>> You asked about products Pfizer is interested in. They were about to license AzaSite from InsiteVision just before all deals stopped 4 months ago due to their realignment of management. Now that evolution is over. look for this deal to occur in the next 3 weeks. It should double the stock at Insite. <<
FWIW—I’m just a messenger.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.